Publishing Principles
Editorial and publication principles
1. Scope
The AIBIOOS Academic Publications channel covers original articles, reviews, thematic commentaries, observation summaries, and collection-oriented publications across artificial intelligence, life science, health technology, functional materials, translational medicine, regulatory science, and system-level platform development.
The Latest Insights channel organizes public scientific, regulatory, industrial, and academic signals to help readers follow AI + life science developments. These summaries are not original research papers and do not imply collaboration, authorization, endorsement, or advisory relationships with referenced institutions or experts.
2. Sources and Evidence Boundaries
Articles should prioritize traceable sources, including peer-reviewed papers, PubMed or publisher records, DOI entries, university and research-institution materials, regulatory documents, formal press releases, and authoritative databases.
When discussing commercial ingredients, product technologies, or early-stage research, authors and editors should distinguish peer-reviewed evidence, clinical studies, in vitro experiments, animal work, supplier materials, media reports, and research hypotheses rather than treating promotional materials as clinical conclusions.
3. Authorship, Translation, and Review
Authored articles should clarify author identity, submission or invitation status, first-publication status, and relevant permissions. Bilingual editing may improve readability, but it should not alter the author's core argument, evidence boundaries, or risk statements.
If an article includes images, tables, paper figures, third-party data, or expert materials, the author or editorial team should confirm public-use permissions, citation format, and necessary explanatory notes.
4. Health and Product-Claim Boundaries
Medical, nutritional, cosmetic, health-technology, and life-science content on AIBIOOS is intended for academic exchange, research judgment, and product-development reference. It does not constitute diagnosis, treatment advice, or a drug-efficacy claim.
For disease, medication, medical-device, or personal health decisions, readers should consult qualified physicians, pharmacists, dietitians, or other relevant professionals.
5. Corrections, Updates, and Withdrawal
If factual errors, broken citations, source updates, authorization concerns, or potentially misleading statements are identified, AIBIOOS may correct, annotate, update, or withdraw the relevant page.
For automatically collected or manually curated insight summaries, the editorial team may filter entries by source quality, topical relevance, and readability. Items that do not fit the channel may be unpublished, removed, or replaced in a later update.
6. Submissions and Collaboration
Experts, scholars, researchers, and industry specialists are welcome to submit original articles, reviews, thematic commentaries, and collection proposals. Recommended submission materials include author information, abstract, keywords, citation sources, image-permission notes, and preferred public contact information.
Submit publication-related information through the contact page